Clinical trial
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2019
- Completion date
- December 30, 2025
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.